CELLPROTHERA
LIVE

Serial Number

79284565

Owner

CELLPROTHERA

Attorney

JANET G RICCIUTI

Filing Date

Apr 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELLPROTHERA Trademark

Serial Number: 79284565 • Registration: 6564631

CELLPROTHERA is a trademark filed by CELLPROTHERA on April 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CELLPROTHERA (10 trademarks)

12 rue du Parc
68100 Mulhouse - , FR

Entity Type: 99

Trademark Details

Filing Date

April 1, 2020

Registration Date

November 23, 2021

Published for Opposition

September 7, 2021

Goods & Services

Research and development services of new products in the field of biotechnology, scientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties

Services for medical care and treatment, namely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growth, sampling and isolation for the production of cell and cell-derived human and animal cell products, namely, cell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individuals, namely, behavioral analysis for medical purposes, therapeutic treatment, namely cell therapy for regenerative medicine

Medical apparatus and instruments, namely, medical devices in the nature of human and animal cell, stem cells and cell-derived products and instruments for injection of cell, stem cells and cell-derived products, namely, chambers for culture, centrifugation and isolation of cell, stem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culture, namely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culture, namely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniques, namely, medical device and apparatus for human and animal cell selection, for human cell immune and for cell dimension selection for the cell-based diagnosis and treatment

Biological preparations for cell cultures, cell culture media, culture media for cell growth for medical biotechnology, biological reagents for molecular biology, chemical reagents for medical use for biological processes, carriers of culture media for medical use, cellular function activating agents, serums, antibodies, all these products being for medical use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 10, 2022 FICS
FINAL DISPOSITION PROCESSED
May 10, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 23, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 29, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 6, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 6, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 21, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 8, 2021 GNFN
FINAL REFUSAL E-MAILED
Mar 8, 2021 GNFR
FINAL REFUSAL WRITTEN
Mar 8, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jun 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 7, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 30, 2020 SDRC